Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1

OBJECTIVES: The aim of this study was to understand how demographic and treatment-related factors impact responses to fostemsavir-based regimens. DESIGN: BRIGHTE is an ongoing phase 3 study evaluating twice-daily fostemsavir 600 mg and optimized background therapy (OBT) in heavily treatment-experien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ackerman, Peter, Thompson, Melanie, Molina, Jean-Michel, Aberg, Judith, Cassetti, Isabel, Kozal, Michael, Castagna, Antonella, Martins, Marcelo, Ramgopal, Moti, Sprinz, Eduardo, Treviño-Pérez, Sandra, Streinu-Cercel, Adrian, Latiff, Gulam H., Pialoux, Gilles, Kumar, Princy N., Wang, Marcia, Chabria, Shiven, Pierce, Amy, Llamoso, Cyril, Lataillade, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183480/
https://www.ncbi.nlm.nih.gov/pubmed/33946085
http://dx.doi.org/10.1097/QAD.0000000000002851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183480/
https://www.ncbi.nlm.nih.gov/pubmed/33946085
http://dx.doi.org/10.1097/QAD.0000000000002851

Ejemplares similares